Bdpalbo 100mg Capsule

1. Product Introduction

Bdpalbo 100mg Capsule contains Palbociclib, a targeted cancer therapy classified as a CDK4/6 inhibitor. It is primarily prescribed for the treatment of certain types of advanced or metastatic breast cancer. This medication works by slowing the growth of cancer cells, making it a vital component in hormone receptor-positive (HR+), HER2-negative breast cancer treatment protocols.

Palbociclib selectively inhibits cyclin-dependent kinases 4 and 6, proteins that are involved in cell cycle regulation. By blocking these kinases, it halts cancer cell proliferation and helps in controlling tumor progression. Bdpalbo is often used in combination with hormone therapies like letrozole or fulvestrant for maximum efficacy.

This oral capsule allows for a convenient method of delivery, providing patients with an effective and manageable treatment option for long-term cancer control.

2. Uses of This Medicine

Bdpalbo 100mg Capsule is primarily used for:

• Advanced or Metastatic Breast Cancer:
  Specifically for HR-positive, HER2-negative breast cancer in postmenopausal women or in men. It is often prescribed:

  • In combination with an aromatase inhibitor (e.g., letrozole) as initial endocrine-based therapy.

  • Alongside fulvestrant in patients whose disease has progressed following hormone therapy.

Doctors may also consider its use in other investigational cancer treatments where CDK4/6 inhibition plays a therapeutic role.

3. Benefits of This Medicine

Bdpalbo 100mg Capsule offers a range of benefits for eligible breast cancer patients:

• Targeted Therapy:
  It specifically targets cancer cell proliferation without broadly suppressing the immune system, making it more tolerable than traditional chemotherapy.

• Improves Progression-Free Survival:
  Clinical trials have shown that Palbociclib significantly extends the time patients live without their cancer worsening.

• Oral Administration:
  Easy-to-swallow capsules offer convenience over IV chemotherapy, enabling home-based treatment with fewer hospital visits.

• Combination-Friendly:
  Enhances the effectiveness of hormonal therapies, giving patients a better chance at controlling tumor growth.

• Delays Need for Chemotherapy:
  For many patients, Bdpalbo helps delay the necessity of more toxic treatment options like chemotherapy.

4. Side Effects

While Bdpalbo is generally well-tolerated, some patients may experience side effects. Regular monitoring and communication with your healthcare provider are essential to manage these reactions.

Common Side Effects:

• Neutropenia (Low white blood cell count) – most common side effect

• Fatigue

• Nausea

• Diarrhea or constipation

• Hair thinning

• Mouth sores

• Infections (due to low immunity)

Serious Side Effects (Rare but Possible):

• Severe infections due to neutropenia

• Lung inflammation (pneumonitis)

• Liver enzyme abnormalities

• Blood clot formation

Your doctor may order regular blood tests to monitor your blood cell counts and liver function during treatment. In some cases, dose adjustments or temporary pauses in treatment may be required.

5. Frequently Asked Questions (FAQ)

Q1. How should I take Bdpalbo 100mg Capsule?

Take Bdpalbo once daily with food, around the same time each day. It is typically prescribed on a 21 days on, 7 days off schedule per 28-day cycle.

Q2. Can Bdpalbo be used alone?

No. It is most effective when used in combination with hormonal therapies such as letrozole or fulvestrant.

Q3. What should I do if I miss a dose?

If you miss a dose, skip it and take the next dose as scheduled. Do not double the dose to make up for a missed one.

Q4. Can I take Bdpalbo during pregnancy?

No. Palbociclib can harm the unborn baby. Women of childbearing age should use effective contraception during treatment and for at least 3 weeks after the last dose.

Q5. Is it safe during breastfeeding?

Avoid breastfeeding during treatment and for at least 3 weeks after the final dose, as the drug may pass into breast milk and harm the infant.